Skip to content
New StartMD
Open menu
Formula reviewEducation only

Focus

Pinealon + PE-22-28 + Selank

Available as a blendSee the blends in the catalog

The full picture

What Focus is — in plain English.

An educational overview: what it is, what people use it for, how it works, and who it is not for. This is not a grade or a claim of effectiveness.

What's in it

PEPTIDEROLE IN THIS BLEND
PinealonA short 'bioregulator' peptide proposed to support neuronal survival and resilience. Early research only — essentially no human data.
PE-22-28An experimental TREK-1 blocker studied in animals for fast mood effects. Never tested in people.
SelankA Russian-approved anti-anxiety peptide with small human trials, included to steady stress and mood. The most evidenced of the three.

The combination logic

The idea behind Focus is to pair mental resilience with mood support: Selank to ease background anxiety, with Pinealon and PE-22-28 added for their proposed neuroprotective and mood effects. Be clear-eyed about the evidence, though. Of the three, only Selank has any human trials, and those are small and Russian. Pinealon's support is laboratory and animal work, and PE-22-28 has been studied only in animals. The rationale for combining them is mechanistic and theoretical, not the result of any trial of this blend.

Is there evidence for the combination, or only for the parts? Neither the blend nor two of its three components has been tested in people. This is among the most experimental formulas in the catalog, and it is presented honestly as such.

What it's used for

USED FORIN SHORT
Focus and mental clarityThe intended purpose, drawn mostly from the components' proposed effects rather than from any trial of the blend.
Calm without sedationSelank's contribution, and the best-supported element of the formula.
Neuroprotection and resilienceA theoretical rationale from Pinealon and PE-22-28. Not established in people.

Overlaps & stacked risks

  • Two of the three components have essentially no human safety data, so the blend's safety in people is largely unknown.
  • Combining three neuroactive peptides stacks their individual unknowns rather than cancelling them out.
  • Anyone with a mood disorder should not treat this as a substitute for evaluated care.

Who it is not for

  • Anyone seeking treatment for depression, anxiety, or another mental-health condition in place of evaluated, human-tested care.
  • Pregnant or breastfeeding patients, or anyone trying to conceive.
  • Children and adolescents.
  • Anyone on psychiatric medication, given the absence of human interaction data for two of the three peptides.
  • Competitive athletes subject to anti-doping testing.

Who it suits

Realistically, this formula suits someone who understands they are considering a largely experimental, research-grade blend, who has no contraindicating history, and who has discussed the thin evidence base candidly with their provider. A provider may reasonably decline to prescribe it.

Who makes this, and under what rules

Everything dispensed here is prepared by a licensed 503A compounding pharmacy — not bought from a supplier and repackaged, and not sourced from an online seller. That designation carries specific, enforceable obligations:

  • A prescription in your name. Compounded from a prescription for one identified patient, after an evaluation.
  • Licensed and inspected. A state license, subject to inspection by the state board of pharmacy.
  • Sterile preparation to a published standard. USP standards.
  • A paper trail. A lot number and beyond-use date on every preparation.

A compounded preparation is not an FDA-approved medicine. This page describes Focus for general educational purposes. It is not medical advice and does not replace a consultation with a licensed provider. Because two of the three components have no human testing, a licensed provider may decline to prescribe this formula; individual results vary, and a combination product carries the risks and the unknowns of each included peptide.

Products are available only by prescription after a consultation with a licensed provider, who decides whether treatment is appropriate. Many compounds described here are not FDA-approved medicines and have not been tested in people for the uses described; information on this site is educational and is not medical advice.